Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis

A subanalysis of a randomized clinical trial indicated sepsis survival benefit from interleukin (IL)-1 blockade in patients with features of the macrophage activation-like syndrome (MALS). This study aimed to ...

About the Author

The Digitalis CPD trawler searches the web for all the latest news and journals.